Fiera Capital (Canada)
VKTX icon

Fiera Capital (Canada)’s Viking Therapeutics VKTX Stock Holding History

Fiera Capital (Canada)’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-272,956
Closed -$7.17M – 464
2025
Q3 		$7.17M Sell
272,956
-6,287
-2% -$188K 0.02% 219
2025
Q2 		$7.4M Buy
279,243
+3,281
+1% +$86.4K 0.03% 205
2025
Q1 		$6.66M Buy
275,962
+6,407
+2% +$202K 0.02% 208
2024
Q4 		$10.8M Sell
269,555
-21,763
-7% -$1.24M 0.03% 178
2024
Q3 		$18.4M Buy
+291,318
New +$17.1M 0.06% 159
2024
Q1 		– Sell
-52,654
Closed -$980K – 535
2023
Q4 		$980K Hold
52,654
– – ﹤0.01% 368
2023
Q3 		$583K Hold
52,654
– – ﹤0.01% 404
2023
Q2 		$854K Hold
52,654
– – ﹤0.01% 363
2023
Q1 		$877K Hold
52,654
– – ﹤0.01% 368
2022
Q4 		$495K Hold
52,654
– – ﹤0.01% 436
2022
Q3 		$143K Hold
52,654
– – ﹤0.01% 538
2022
Q2 		$152K Hold
52,654
– – ﹤0.01% 572
2022
Q1 		$158K Hold
52,654
– – ﹤0.01% 586
2021
Q4 		$242K Sell
52,654
-1,016,356
-95% -$5.7M ﹤0.01% 576
2021
Q3 		$6.71M Sell
1,069,010
-16,386
-2% -$101K 0.02% 183
2021
Q2 		$6.5M Sell
1,085,396
-30,020
-3% -$178K 0.02% 184
2021
Q1 		$7.05M Buy
1,115,416
+8,556
+0.8% +$60.2K 0.02% 179
2020
Q4 		$6.23M Sell
1,106,860
-20,893
-2% -$127K 0.02% 223
2020
Q3 		$6.56M Sell
1,127,753
-37,337
-3% -$257K 0.02% 207
2020
Q2 		$8.4M Sell
1,165,090
-25,421
-2% -$169K 0.03% 205
2020
Q1 		$5.57M Sell
1,190,511
-6,307
-0.5% -$38.8K 0.02% 209
2019
Q4 		$9.6M Sell
1,196,818
-108,773
-8% -$793K 0.03% 204
2019
Q3 		$8.98M Sell
1,305,591
-34,969
-3% -$260K 0.03% 207
2019
Q2 		$11.1M Sell
1,340,560
-81,593
-6% -$697K 0.04% 203
2019
Q1 		$14.1M Sell
1,422,153
-37,621
-3% -$315K 0.06% 196
2018
Q4 		$11.2M Buy
+1,459,774
New +$17.5M 0.05% 201

Other funds holding VKTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Fiera Capital (Canada)'s VKTX Position: Q4 2025 in Review

Fiera Capital (Canada) sold out of Viking Therapeutics (VKTX) in Q4 2025, closing a stake of 272,956 shares — an estimated $7.17M sold.

Fiera Capital (Canada) first reported a position in VKTX in Q4 2018 and held it in 26 quarters. The position peaked at $18.4M in Q3 2024. 426 funds tracked by Wall St. Rank hold VKTX as of Q4 2025.

  • Fiera Capital (Canada) reported no remaining Viking Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Fiera Capital (Canada) sold 272,956 Viking Therapeutics shares in Q4 2025, an estimated $7.17M.
  • Fiera Capital (Canada) first reported a position in Viking Therapeutics in Q4 2018 and held it in 26 quarters.
  • Fiera Capital (Canada)'s Viking Therapeutics position peaked at $18.4M in Q3 2024.
  • 426 funds tracked by Wall St. Rank held Viking Therapeutics as of Q4 2025.

Based on Fiera Capital (Canada)'s 13F filing for Q4 2025, filed 11 Feb 2026.